Non-small cell lung cancer (NSCLC) constitutes over 80% of lung cancer cases, with its incidence showing an increasing trend [ 2 ].
← all excerpts
miR-4652-3p suppresses glutamine metabolism induced by the inflammatory microenvironment in non-small cell lung cancer by regulating MYC/SLC1A5.
1
—
—